We demonstrate that the HIF2α-guided metabolic shift in lipid metabolism depends on TCF7L2, and the increased lipid synthesis supports the invasive capacity of ccRCC. The gene discussed is TCF7L2; the disease is nonpapillary renal cell carcinoma.